Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Osteoporosis Drugs Market


6. Market Share – Global Osteoporosis Drugs Market

6.1 By Drug Class
6.2 By Route of Administration
6.3 By Type
6.4 By Region


7. Drug Class – Global Osteoporosis Drugs Market

7.1 Bisphosphonates
7.2 Selective Estrogen Inhibitors Modulator (SERM)
7.3 Parathyroid Hormone Therapy
7.4 Calcitonin
7.5 Rank Ligand Inhibitors
7.6 Others


8. Route of Administration – Global Osteoporosis Drugs Market

8.1 Oral
8.2 Injectable
8.3 Others


9. Type – Global Osteoporosis Drugs Market

9.1 Branded
9.2 Generic


10. Region – Lithium-Ion Battery Market

10.1 North America
10.2 Asia Pacific
10.3 Europe
10.4 Middle East and Africa
10.5 South America


11. Porters Five Forces

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes


12. Company Analysis

12.1 Eli Lilly and Company

12.1.1 Overview
12.1.2 Recent Development
12.1.3 Financial Insight

12.2 Pfizer Inc.

12.2.1 Overview
12.2.2 Recent Developmen
12.2.3 Financial Insight

12.3 F. Hoffmann-La Roch

12.3.1 Overview
12.3.2 Recent Development
12.3.3 Financial Insight

12.4 Teva Pharmaceutical Industries Ltd.

12.4.1 Overview
12.4.2 Recent Development
12.4.3 Financial Insight

12.5 GlaxoSmithKline plc.

12.5.1 Overview
12.5.2 Recent Development
12.5.3 Financial Insight

12.6 Novartis International AG

12.6.1 Overview
12.6.2 Recent Development
12.6.3 Financial Insight

12.7 Merck & Co. Inc.

12.7.1 Overview
12.7.2 Recent Development
12.7.3 Financial Insight

12.8 Amgen Inc.

12.8.1 Overview
12.8.2 Recent Development
12.8.3 Financial Insight



List of Figures

Figure-01: Global – Osteoporosis Drugs Market (Billion US$), 2018 – 2021
Figure-02: Global – Forecast for Osteoporosis Drugs Market (Billion US$), 2022 – 2027
Figure-03: Drug Class – Bisphosphonates Market (Billion US$), 2018 – 2021
Figure-04: Drug Class – Forecast for Bisphosphonates Market (Billion US$), 2022 – 2027
Figure-05: Drug Class – Selective Estrogen Inhibitors Modulator (SERM) Market (Million US$), 2018 – 2021
Figure-06: Drug Class – Forecast for Selective Estrogen Inhibitors Modulator (SERM) Market (Million US$), 2022 – 2027
Figure-07: Drug Class – Parathyroid Hormone Therapy Market (Billion US$), 2018 – 2021
Figure-08: Drug Class – Forecast for Parathyroid Hormone Therapy Market (Billion US$), 2022 – 2027
Figure-09: Drug Class – Calcitonin Market (Million US$), 2018 – 2021
Figure-10: Drug Class – Forecast for Calcitonin Market (Million US$), 2022 – 2027
Figure-11: Drug Class – Rank Ligand Inhibitors Market (Billion US$), 2018 – 2021
Figure-12: Drug Class – Forecast for Rank Ligand Inhibitors Market (Billion US$), 2022 – 2027
Figure-13: Drug Class – Others Market (Billion US$), 2018 – 2021
Figure-14: Drug Class – Forecast for Others Market (Billion US$), 2022 – 2027
Figure-15: Route of Administration – Oral Market (Billion US$), 2018 – 2021
Figure-16: Route of Administration – Forecast for Oral Market (Billion US$), 2022 – 2027
Figure-17: Route of Administration – Injectable Market (Billion US$), 2018 – 2021
Figure-18: Route of Administration – Forecast for Injectable Market (Billion US$), 2022 – 2027
Figure-19: Route of Administration – Others Market (Million US$), 2018 – 2021
Figure-20: Route of Administration – Forecast for Others Market (Million US$), 2022 – 2027
Figure-21: Type – Branded Market (Billion US$), 2018 – 2021
Figure-22: Type – Forecast for Branded Market (Billion US$), 2022 – 2027
Figure-23: Type – Generic Market (Billion US$), 2018 – 2021
Figure-24: Type – Forecast for Generic Market (Billion US$), 2022 – 2027
Figure-25: North America – Osteoporosis Drugs Market (Billion US$), 2018 – 2021
Figure-26: North America – Forecast for Osteoporosis Drugs Market (Billion US$), 2022 – 2027
Figure-27: Asia Pacific – Osteoporosis Drugs Market (Billion US$), 2018 – 2021
Figure-28: Asia Pacific – Forecast for Osteoporosis Drugs Market (Billion US$), 2022 – 2027
Figure-29: Europe – Osteoporosis Drugs Market (Billion US$), 2018 – 2021
Figure-30: Europe – Forecast for Osteoporosis Drugs Market (Billion US$), 2022 – 2027
Figure-31: Middle East and Africa – Osteoporosis Drugs Market (Million US$), 2018 – 2021
Figure-32: Middle East and Africa – Forecast for Osteoporosis Drugs Market (Million US$), 2022 – 2027
Figure-33: South America – Osteoporosis Drugs Market (Million US$), 2018 – 2021
Figure-34: South America – Forecast for Osteoporosis Drugs Market (Million US$), 2022 – 2027
Figure-35: Eli Lilly and Company – Global Revenue (Billion US$), 2018 – 2021
Figure-36: Eli Lilly and Company – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-37: Pfizer Inc. – Global Revenue (Billion US$), 2018 – 2021
Figure-38: Pfizer Inc. – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-39: F. Hoffmann-La Roche – Global Revenue (Billion US$), 2018 – 2021
Figure-40: F. Hoffmann-La Roche – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-41: Teva Pharmaceutical Industries Ltd. – Global Revenue (Billion US$), 2018 – 2021
Figure-42: Teva Pharmaceutical Industries Ltd. – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-43: GlaxoSmithKline plc. – Global Revenue (Billion US$), 2018 – 2021
Figure-44: GlaxoSmithKline plc. – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-45: Novartis International AG – Global Revenue (Billion US$), 2018 – 2021
Figure-46: Novartis International AG – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-47: Merck & Co. Inc. – Global Revenue (Billion US$), 2018 – 2021
Figure-48: Merck & Co. Inc. – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-49: Amgen Inc. – Global Revenue (Billion US$), 2018 – 2021
Figure-50: Amgen Inc. – Forecast for Global Revenue (Billion US$), 2022 – 2027

List of Tables

Table-01: Global – Osteoporosis Drugs Market Share by Drug Class (Percent), 2018 – 2021
Table-02: Global – Forecast for Osteoporosis Drugs Market Share by Drug Class (Percent), 2022 – 2027
Table-03: Global – Osteoporosis Drugs Market Share by Route of Administration (Percent), 2018 – 2021
Table-04: Global – Forecast for Osteoporosis Drugs Market Share by Route of Administration (Percent), 2022 – 2027
Table-05: Global – Osteoporosis Drugs Market Share by Type (Percent), 2018 – 2021
Table-06: Global – Forecast for Osteoporosis Drugs Market Share by Type (Percent), 2022 – 2027
Table-07: Global – Osteoporosis Drugs Market Share by Region (Percent), 2018 – 2021
Table-08: Global – Forecast for Osteoporosis Drugs Market Share by Region (Percent), 2022 – 2027